Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Oral Contraceptives

- Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size | Oral Contraceptive
- Completed

Study Title: A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Teva Identifier: DSG-OI-101

ClinicalTrials.gov Identifier: NCT01291004

Study Status: Completed

Trial Condition(s): Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size | Oral Contraceptive

Interventions: Drug: Desogestrel/ethinyl estradiol and ethinyl estradiol | Drug: 28-day drospirenone oral contraceptive | Drug: 28-day levonorgestrel oral contraceptive

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female

Age Range: 18 Years to 35 Years

Trial Duration: 01/01/2011 - 03/01/2012

Phase: Phase 1

Study Type

Interventional